Loading
Loading…
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Status |
|---|---|---|
| 1 | Accepted-Technical | Accepted-Technical Offer technically acceptable |
| 2 | Accepted-Technical CIPLA HOUSE PENINSULA BUSINESS PARK GANPATRAO KADAM MARG LOWER PAREL MUMBAI MAHARASHTRA 400013 | MUMBAI | MAHARASHTRA | 400013 | Accepted-Technical Offer technically acceptable |
| 3 | Accepted-Technical 7 1 27 AMEERPET HYDERABAD TELANGANA INDIA 500016 | HYDERABAD | HYDERABAD | TELANGANA | 500016 | Accepted-Technical Offer technically acceptable |
| 4 | Accepted-Technical 208 PHASE 3 OKHLA INDUSTRIAL ESTATE NEW DELHI DELHI 110020 | SOUTH EAST DELHI | DELHI | 110020 | Accepted-Technical Offer technically acceptable |
| 5 | Accepted-Technical | Accepted-Technical Offer technically acceptable |
Tender Value
Refer Docs
Closing Date
16 Dec 2025, 3:30 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
JAY KUMAR
BHEL MAIN HOSPITAL HARIDWAR
LEVOCETIRIZINE 2.5MG PLUS MONTELUKA ST 4 MG KID TAB
2025_BHEL_55605_1
265 H/ MDX/5/0265P1
Limited
Drugs and Pharmaceutical Products
Supply
240 days
BHEL MAIN HOSPITAL HARIDWAR
Please refer Tender documents.
2 documents required · 2 mandatory
₹0
Exempted
3 Jan 2026
5 Dec 2025
16 Dec 2025
5 Dec 2025
16 Dec 2025
5 Dec 2025
tech_eval.pdf
Restricted Tender
This is a Limited tender. Documents are accessible only to bidders authorized by the issuing authority on the government portal.
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .